We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+14.07%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$6.45B
AUM Growth
+$725M
Cap. Flow
-$581M
Cap. Flow %
-9%
Top 10 Hldgs %
18%
Holding
1,317
New
227
Increased
165
Reduced
129
Closed
313

Sector Composition

Rank Sector Weight
1 Financials 13.98%
2 Technology 9.11%
3 Energy 6.09%
4 Healthcare 4.57%
5 Utilities 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEL.WS
651
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$525K 0.01%
50,000
MNTN.WS
652
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$524K 0.01%
50,000
GTACW
653
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$523K 0.01%
50,000
SVNAW
654
DELISTED
7 Acquisition Corp Warrant
SVNAW
$522K 0.01%
50,000
HCA icon
655
HCA Healthcare
HCA
$92.8B
$521K 0.01%
+1,977
New +$502K
NFNT.WS
656
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$521K 0.01%
50,000
UTAAW
657
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$521K 0.01%
50,000
USCTW
658
DELISTED
Roth CH Acquisition Co. Warrant
USCTW
$520K 0.01%
50,000
FIACW
659
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$520K 0.01%
50,000
GCTS
660
GCT Semiconductor Holding
GCTS
$171M
$519K 0.01%
50,000
ROSEW
661
DELISTED
Rose Hill Acquisition Corporation Warrant
ROSEW
$518K 0.01%
50,000
PNTM.WS
662
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$517K 0.01%
50,000
VMGAW
663
DELISTED
VMG Consumer Acquisition Corp. Warrant
VMGAW
$517K 0.01%
50,000
CFIVW
664
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$516K 0.01%
50,000
CSII
665
DELISTED
Cardiovascular Systems, Inc.
CSII
$516K 0.01%
+25,982
New +$449K
NRAC
666
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$514K 0.01%
50,000
EOCW.WS
667
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$512K 0.01%
50,000
MSCI icon
668
MSCI
MSCI
$42.1B
$512K 0.01%
915
+259
+39% +$137K
BLEUW
669
DELISTED
bleuacacia ltd Warrants
BLEUW
$511K 0.01%
50,000
AILEW
670
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$511K 0.01%
50,000
FZT.WS
671
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$511K 0.01%
50,000
VRDN icon
672
Viridian Therapeutics
VRDN
$2.15B
$509K 0.01%
20,000
-30,000
-60% -$962K
GFX.WS
673
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$507K 0.01%
50,000
SDACW
674
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$505K 0.01%
50,000
TPR icon
675
Tapestry
TPR
$30.5B
$491K 0.01%
11,378
+1,661
+17% +$71.3K

Similar funds

LMR Partners's Q1 2023 Portfolio in Review

As of Q1 2023, LMR Partners held 1,317 positions worth $6.45B, up 13% from $5.73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

LMR Partners withdrew a net $581M in Q1 2023, closing 313 positions and reducing 129 holdings. Its most notable exit was Bank of New York Mellon, an estimated $60M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Energy.

Against the trend, LMR Partners opened a new position in AstraZeneca worth $42.7M.

  • LMR Partners's largest Q1 2023 buy was AstraZeneca: 307,414 shares worth $42.7M.
  • LMR Partners added most to First Horizon in Q1 2023, an estimated $77.4M increase.
  • LMR Partners's biggest Q1 2023 reduction was TSMC, cutting an estimated $121M.
  • LMR Partners fully exited Bank of New York Mellon in Q1 2023, selling an estimated $60M.
  • LMR Partners's ten largest holdings make up 18% of its $6.45B portfolio in Q1 2023.
  • LMR Partners opened 227 new positions and closed 313 in Q1 2023.
  • LMR Partners's portfolio value rose 13% quarter-over-quarter to $6.45B.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.